Survey of Medical Directors

Questions about influenza outbreak management and use of antivirals

Question Title

* 1. Within your facility, an outbreak of influenza is (check any that apply):

Question Title

* 2. What administrative procedures do you put in place when an outbreak is identified (check all that apply)?

Question Title

* 3. What antiviral medications do you typically use to treat individual residents when you have an outbreak (check all that apply)?

Question Title

* 4. What antiviral medications would you consider appropriate to use for prophylaxis of individual residents against influenza when you have an outbreak (check all that apply)?

Question Title

* 5. There are three neuraminidase inhibitors approved for both treatment and prophylaxis of influenza (baloxavir, oseltamivir, and inhaled zanamivir). Do you consider them to be equally acceptable options for your nursing home residents for outbreak control?

Question Title

* 6. If you responded “No” to question 5, please indicate why?

Question Title

* 7. Would you, or facilities you work in, consider participating in a clinical trial where facilities were randomized to receive either baloxavir (at least one dose) or oseltamivir (at least two weeks of renally adjusted prophylaxis) as standard of care, to be administered according to the package insert, at no cost for management of influenza outbreaks for the 2021-2022 influenza season?

Question Title

* 8. Additional comments related to flu outbreaks and antivirals?

Question Title

* 9. Please confirm you are a nursing home medical director.

0 of 9 answered
 

T